Plasma-only ctDNA-Guided MRD Detection in Patients with CRC-Response.
作者信息
Parikh Aparna R, Corcoran Ryan B
机构信息
Department of Medicine, Division of Hematology & Oncology, Massachusetts General Hospital Cancer Center & Harvard Medical School, Boston, Massachusetts.
出版信息
Clin Cancer Res. 2021 Dec 1;27(23):6614-6615. doi: 10.1158/1078-0432.CCR-21-3306.
Abstract
摘要
相似文献
[1]
Plasma-only ctDNA-Guided MRD Detection in Patients with CRC-Response.
Clin Cancer Res. 2021-12-1
[2]
Plasma-only ctDNA-Guided MRD Detection in Patients with CRC-Letter.
Clin Cancer Res. 2021-12-1
[3]
Circulating Tumor DNA in Precision Oncology and Its Applications in Colorectal Cancer.
Int J Mol Sci. 2022-4-18
[4]
[5]
Perioperative Dynamic Changes in Circulating Tumor DNA in Patients with Lung Cancer (DYNAMIC).
Clin Cancer Res. 2019-8-22
[6]
Perioperative ctDNA-Based MRD Detection in NSCLC-Response.
Clin Cancer Res. 2022-8-2
[7]
[8]
[9]
[10]
Early stage NSCLC - challenges to implementing ctDNA-based screening and MRD detection.
Nat Rev Clin Oncol. 2018-9
引用本文的文献
[1]
[2]
本文引用的文献
[1]
[2]
[3]
[4]
[5]
[6]
Mutation tracking in circulating tumor DNA predicts relapse in early breast cancer.
Sci Transl Med. 2015-8-26
Zotero 插件